INmune Bio Appoints Biotechnology Executive Edgardo Baracchini as New Board Member

San Diego Biotechnology Network
San Diego Biotechnology Network
INmune Bio Appoints Biotechnology Executive Edgardo Baracchini as New Board Member
Loading
/

LA JOLLA, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient?s innate immune system to fight disease, is pleased to announce that Edgardo (Ed) Baracchini, Ph.D., has joined the company?s board of directors.


ADVERTISEMENT — Advertise With Biotech Networks